Who Makes Mounjaro Weight Loss? Understanding the Manufacturer and Its Impact on Your Journey

Last reviewed: July 17, 2026

Last updated: July 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro is manufactured by Eli Lilly and contains tirzepatide, a dual GLP-1 and GIP receptor agonist approved by the FDA in 2022 for weight loss. While brand-name Mounjaro remains expensive and often faces insurance barriers, compounded tirzepatide from licensed 503A pharmacies delivers the identical active ingredient with personalized dosing flexibility and pricing at $289/mo month-to-month, or from $249/mo on the 6-month plan.

Who Manufactures Mounjaro and How It Works

Eli Lilly developed and manufactures Mounjaro as a branded pharmaceutical product. Tirzepatide, the active ingredient, mimics two natural hormones—glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)—that regulate appetite and blood sugar. This dual-action mechanism helps reduce hunger signals to the brain while slowing stomach emptying, creating sustained satiety and weight loss.

Clinical trials demonstrated that patients taking tirzepatide lost between 15% and 22% of body weight over 72 weeks, depending on dose level. The medication works by activating receptors in the hypothalamus, the brain region controlling food intake and energy expenditure. This biological pathway explains why tirzepatide produces meaningful, sustained weight loss for most patients who remain consistent with treatment.

Brand Name Mounjaro vs. Compounded Tirzepatide Options

Brand-name Mounjaro carries a retail price exceeding $1,000 per month before insurance, making it inaccessible for many patients. Insurance denials, prior authorization delays, and coverage gaps leave patients searching for alternatives. Compounded tirzepatide from licensed 503A pharmacies contains the same active pharmaceutical ingredient but is prepared by state-regulated compounding facilities rather than Eli Lilly's manufacturing plants.

The key difference lies in accessibility and flexibility. Compounded tirzepatide can be dosed incrementally to match individual metabolism and tolerance, whereas pre-filled Mounjaro pens come in fixed doses. PlexusDx sources compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan, with no insurance requirement, no membership fees, and HSA/FSA eligibility—removing financial barriers that prevent people from starting treatment.

Understanding Licensed 503A Compounding Pharmacies

503A compounding pharmacies are state-licensed facilities that prepare customized medications under federal and state oversight. These pharmacies must meet strict quality, sterility, and ingredient-verification standards set by state pharmacy boards and the United States Pharmacopeia (USP). Each compounded medication batch undergoes rigorous testing for potency, purity, and safety before dispensing to patients.

PlexusDx exclusively partners with licensed 503A compounding pharmacies to source compounded tirzepatide, never 503B outsourcing facilities. This distinction matters because 503A pharmacies operate under direct state regulation and patient-specific preparation standards, ensuring that your medication is made to your exact prescription. Patients receive documented pharmaceutical certificates of analysis confirming ingredient quality and concentration for every shipment.

How Genetic Testing Personalizes Your Tirzepatide Response

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The test analyzes five core genetic variants that shape appetite regulation, energy storage, and GLP-1 receptor sensitivity. Patients carrying specific variants in the GIPR rs1800437 gene, for example, may experience faster hunger suppression at lower tirzepatide doses, while others with FTO rs9939609 variants may require gradual dose escalation. Genetic insights available after your first month of treatment help PlexusDx clinicians fine-tune your dose with precision, reducing trial-and-error adjustments and accelerating your weight loss results.

Tirzepatide Pricing and Commitment Options at PlexusDx

PlexusDx offers compounded tirzepatide injections at a flat monthly rate at $289/mo month-to-month, or from $249/mo on the 6-month plan, with three commitment tiers providing consistent pricing as your clinical dose adjusts upward. Your dose may need to go up over time, but your price won't—a transparent pricing model that protects patients from unexpected out-of-pocket increases. All patients receive access to telehealth clinician consultations, dose optimization support, and shipment directly to their home.

Oral tirzepatide is also available at $349/mo (or $279/mo on the 6-month plan) for patients preferring tablet formulation, though injections deliver faster absorption and more predictable appetite suppression. Dual-compound options like GLP-Squared injection (combining semaglutide and tirzepatide) are $289/mo month-to-month, or from $249/mo on the 6-month plan for patients needing enhanced weight loss synergy. HSA and FSA accounts cover all PlexusDx medications, providing additional tax-advantaged savings for eligible patients in all 50 states.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded tirzepatide the same as brand-name Mounjaro?

Both contain identical tirzepatide active pharmaceutical ingredient, but compounded tirzepatide is prepared by licensed 503A pharmacies with flexible dosing, while Mounjaro is manufactured by Eli Lilly in fixed-dose pens. Compounded versions cost significantly less and require no insurance, making them accessible to more patients seeking weight loss treatment.

How much weight can I expect to lose on tirzepatide?

No — the Precision Peptide Genetic Test does not predict your response to Mounjaro or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Why does PlexusDx use 503A compounding pharmacies instead of 503B?

503A pharmacies operate under direct state pharmacy board regulation and prepare medications specifically for individual patients, ensuring higher quality oversight than 503B outsourcing facilities. PlexusDx prioritizes patient safety and regulatory compliance by exclusively partnering with licensed 503A compounders that provide documented potency and purity certificates with every shipment.

What is the Precision Peptide Genetic Test and when should I take it?

The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways and identifies genetic variants affecting your GLP-1 and GIP receptor sensitivity, appetite regulation, and weight-storage genes like FTO and MC4R. Results guide your clinician in personalizing your dose, choosing between injection and oral formulations, and predicting long-term weight loss success.

Can I use my HSA or FSA to pay for PlexusDx tirzepatide?

Yes, all PlexusDx compounded medications including tirzepatide injections and the Precision Peptide Genetic Test are HSA and FSA eligible, allowing you to use pre-tax healthcare dollars to reduce your out-of-pocket costs. PlexusDx accepts HSA/FSA cards directly at checkout in all 50 states.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.